Boston Scientific Buys EndoChoice, Mulls De-FUSEing Potential Weakness

Boston Scientific is making a significant investment in its endoscopy portfolio as it strikes a $210m deal to buy colonoscopy specialist EndoChoice. The Natick, Massachusetts, group added that it will be “evaluating strategic options” for EndoChoice’s Fuse colonoscope.

3d render illustration of human digestive system - front view
• Source: shutterstock.com

[Editor’s note: This story was updated on Sept.28, 2016 to include a comment from Boston Scientific in the fifth paragraph.]

Boston Scientific Corp. has inked a $210m deal to acquire EndoChoice Holdings Inc., a specialist in gastrointestinal endoscopy...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Gastroenterology

More from Device Area